Medinice S.A
Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technol… Read more
Market Cap & Net Worth: Medinice S.A (ICE)
Medinice S.A (WAR:ICE) has a market capitalization of $80.05 Million (zł332.84 Million) as of March 18, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #21295 globally and #119 in its home market, demonstrating a 9.91% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medinice S.A's stock price zł43.25 by its total outstanding shares 7695648 (7.70 Million).
Medinice S.A Market Cap History: 2018 to 2026
Medinice S.A's market capitalization history from 2018 to 2026. Data shows growth from $11.84 Million to $80.05 Million (20.38% CAGR).
Medinice S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medinice S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
76.79x
Medinice S.A's market cap is 76.79 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
0.38x
Medinice S.A's market cap is 0.38 times its annual earnings
1.95x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $11.84 Million | $1.11K | -$1.65 Million | 10671.10x | N/A |
| 2019 | $17.58 Million | $164.39K | -$2.25 Million | 106.96x | N/A |
| 2020 | $32.02 Million | $372.00K | -$3.02 Million | 86.07x | N/A |
| 2021 | $37.76 Million | $288.00K | -$2.88 Million | 131.10x | N/A |
| 2022 | $25.80 Million | $246.00K | -$4.92 Million | 104.88x | N/A |
| 2023 | $18.14 Million | $225.00K | -$5.07 Million | 80.61x | N/A |
| 2024 | $14.44 Million | $188.00K | $37.58 Million | 76.79x | 0.38x |
Competitor Companies of ICE by Market Capitalization
Companies near Medinice S.A in the global market cap rankings as of March 18, 2026.
Key companies related to Medinice S.A by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Medinice S.A Historical Marketcap From 2018 to 2026
Between 2018 and today, Medinice S.A's market cap moved from $11.84 Million to $ 80.05 Million, with a yearly change of 20.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł80.05 Million | +154.41% |
| 2025 | zł31.46 Million | +117.95% |
| 2024 | zł14.44 Million | -20.41% |
| 2023 | zł18.14 Million | -29.70% |
| 2022 | zł25.80 Million | -31.67% |
| 2021 | zł37.76 Million | +17.92% |
| 2020 | zł32.02 Million | +82.11% |
| 2019 | zł17.58 Million | +48.44% |
| 2018 | zł11.84 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Medinice S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $80.05 Million USD |
| MoneyControl | $80.05 Million USD |
| MarketWatch | $80.05 Million USD |
| marketcap.company | $80.05 Million USD |
| Reuters | $80.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.